Skip to main content

Coherus Oncology, Inc 10-Q for FY2020 Q2

Coherus Oncology, Inc. (CHRS)

10-Q 2020-08-06 For: 2020-06-30
View Original
Added on April 09, 2026

About this 10-Q

Coherus Oncology, Inc filed this 10-Q on August 6, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).

Headline figures

Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$135.67M
up 62.6% from $83.43M a year earlier
Net income
$59.03M
Diluted EPS
$0.70
up 118.8% from $0.32 a year earlier